SCHEMBL6136924

SCHEMBL6136924

CN(C)C(=O)Sc1ccc(CC(=O)O)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
AGBL2 Q5U5Z8 1/20 0.39
CYP26A1 O43174 1/20 0.35
CYP26B1 Q9NR63 1/20 0.35
SRC P12931 1/20 0.35
CXCL8 P10145 2/20 0.34
ACHE P22303 1/20 0.33
PTGER4 P35408 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
RIPK1 Q13546 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
AKR1B1 P15121 1/20 0.32
PTGS2 P35354 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29019222 0.75 ALDH1A1 (0.47) ALDH1A1ACHETSHRHPGD
SCHEMBL15956317 0.75 ALDH1A1 (0.39) ALDH1A1AGBL2CYP26A1CYP26B1SRC
SCHEMBL6541372 0.74 CA2 (0.47) ALDH1A1CYP26A1RXRARXRBRXRG
SCHEMBL31584613 0.74 AGBL2 (0.38) AGBL2CYP26A1CYP26B1SRCCXCL8
SCHEMBL11039596 0.74 ERN1 (0.40) ALDH1A1CYP26A1CYP26B1SRCRXRA
SCHEMBL10896532 0.73 RAB9A (0.51) ALDH1A1ACHEHSD17B10
SCHEMBL16879952 0.72 AGBL2 (0.38) AGBL2CYP26A1CYP26B1SRCCXCL8
SCHEMBL17964126 0.72 ALDH1A1 (0.47) ALDH1A1ACHETSHRCYP2C9CYP2C19
SCHEMBL3755853 0.72 ALDH1A1 (0.43) ALDH1A1ACHECYP2C9CYP2C19
SCHEMBL10809189 0.72 ALDH1A1 (0.61) ALDH1A1ACHETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011651-B1 METHOD OF TREATING DIABETES AND RELATED DISEASE STATES MERCK & CO INC (US) 2005-04-27 EP disclosed
EP-1011651-A1 METHOD OF TREATING DIABETES AND RELATED DISEASE STATES Merck & Co., Inc. (US) 2000-06-28 EP disclosed
EP-1011651-A4 METHOD OF TREATING DIABETES AND RELATED DISEASE STATES MERCK & CO INC (US) 2000-06-28 EP disclosed
US-6020382-A Method of treating diabetes and related disease states MERCK & CO., INC. (US) 2000-02-01 US disclosed
US-5847008-A Method of treating diabetes and related disease states MERCK & CO., INC. (US) 1998-12-08 US disclosed
WO-1997027847-A1 METHOD OF TREATING DIABETES AND RELATED DISEASE STATES MERCK & CO., INC. (US) 1997-08-07 WO disclosed
EP-0106565-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-09-10 EP disclosed
EP-0106565-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-25 EP disclosed